During the past decade, Universitaetsklinikum Marburg; Klinik fuer Neurologie conducted 3 clinical trials. In the 10-year time frame, 3 clinical trials started and 1 clinical trials were completed, i.e. on average, 33.3% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 1 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Universitaetsklinikum Marburg; Klinik fuer Neurologie" are "Multiple Sclerosis, Relapsing-Remitting" (2 trials) and "Multiple Sclerosis" (1 trials). Many other conditions were trialed in "Universitaetsklinikum Marburg; Klinik fuer Neurologie" in a lesser frequency.

Most popular intervention types in "Universitaetsklinikum Marburg; Klinik fuer Neurologie" are "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Ocrelizumab" (3 trials), "Antihistamine" (1 trials) and "Methylprednisolone" (1 trials). Other intervention names were less common.

The vast majority of trials in "Universitaetsklinikum Marburg; Klinik fuer Neurologie" are 3 trials for "All" genders.

Currently, there are NaN active trials in "Universitaetsklinikum Marburg; Klinik fuer Neurologie". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Universitaetsklinikum Marburg; Klinik fuer Neurologie, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Universitaetsklinikum Marburg; Klinik fuer Neurologie, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".